Receptors for cholecystokinin and gastrin;Rezeptoren fur cholezystokinin und gastrin

Zeitschrift fur Gastroenterologie

Volumn 37, Issue 5, 1999, Pages 389-401

  De Weerth, A ^a   Blaker M ^a   Von Schrenck, Tammo ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cholecystokinin; Gastrin; Molecular cloning; Receptors; Review; Signal transduction; Structure function analysis

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; GASTRIN; GASTRIN RECEPTOR;

HORMONE STRUCTURE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION; AMINO ACID SEQUENCE; ANIMAL; GENETICS; HUMAN; MOLECULAR CLONING; MOLECULAR GENETICS; PHYSIOLOGY; RAT;

AMINO ACID SEQUENCE; ANIMALS; CHOLECYSTOKININ; CLONING, MOLECULAR; GASTRINS; HUMANS; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, CHOLECYSTOKININ; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033125106     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Johnsen AH, Rehfeld JF. Identification of cholecystokinin/gastrin peptides in frog and turtle. Evidence that cholecystokinin is phylogenetically older than gastrin. Eur J Biochem 1992; 207: 419-28
2. Jensen RT, Gardner JD. Identification and characterization of receptors for secretagogues on pancreatic acinar cells. Federation Proc 1981; 40: 2486-96
3. Wank SA. Cholecystokinin receptors. Am J Physiol 1995; 269: G628-G646
4. Bayliss WM, Starling EH. The mechanism of pancreatic secretion. Proc Roy Soc 1902; 69: 352-3
5. Ivy AC, Goldberg E. A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol 1928; 86: 599-613
6. Harper AA, Raper SS. Pankreozymin, a stimulant of secretion of pancreatic enzymes in extracts of the small intestine. Am J Physiol 1943; 102: 115-25
7. Jorpes JE, Mutt V. Clinical aspects of the gastrointestinal hormones secretin and cholecystokinin. Scand J Gastroenterol 1969; 4: 49-57
8. Edkins JS. On the mechanism of gastric secretion. Proc R Soc Lond 1905; 76: 376
9. Gregory RA, Tracy HJ. The constitution and properties of two gastrins extracted from dog antral mucosa. Gut 1964; 5: 103-17
10. Reeve JR, Eysselein VE Jr., Ho FJ et al. Natural and synthetic CCK-58. Novel reagents for studying cholecystokinin physiology. Ann N Y Acad Sci 1994; 713: 11-21
11. Jensen RT, Lemp GF, Gardner JD. Interactions of COOH-terminal fragments of cholecystokinin with receptors on dispersed acini from guinea pig pancreas. J Biochem 1982; 257: 5554-9
12. Dockray GJ, Debas HT, Walsh JH, Grossman MI. Molecular forms of gastrin in antral mucosa and serum of dogs. Proc Soc Exp Biol Med 1975; 149: 550-3
13. Del Valle J, Sugano K, Yamada T. Glycine-extended processing intermediates of gastrin and cholecystokinin in human plasma. Gastroenterology 1989; 97: 1159-63
14. Gardner JD, Jensen RT. Secretagogue receptors on pancreatic acinar cells. In: Johnson LR et al. (eds.). Physiology of the Gastrointestinal Tract. New York. Raven Press 1987; p 1109-27
15. Sankaran H, Goldfine ID, Deveney CW, Wong KY, Williams JA. Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. J Biol Chem 1980; 255: 1849-53
16. Adler G, Nelson DK, Katschinski M, Beglinger C. Neurohormonal control of human pancreatic, exocrine secretion. Pancreas 1995; 10: 1-13
17. Karlsson S, Ahren B. CCK-8-stimulated insulin secretion in vivo is mediated liy CCKA receptors. Eur J Pharmacol 1992; 213: 145-6
18. Liddle RA, Gertz BJ, Kanayama S et al. Regulation of pancreatic endocrine function by cholecystokinin: Studies with MK-329, a nonpeptide cholecystokinin receptor antagonist. J Clin Endocrinol Metab 1990; 70: 1312-8
19. Zucker KA, Adrian TK, Bilchik AJ, Modlin IM. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals. Am J Phvsiol 1989; 257: G511-G516
20. Qian JM, Rowley WH, Jensen RT. Gastrin and CCK activate phospholipase C and stimulate pepsinogen release by interacting with two distinct receptors. Am J Physiol 1993; 264: 718-28
21. von Schrenck T, Moran TH, Heinz-Erian P, Gardner JD, Jensen RT. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: A comparative study. Am J Physiol 1988; 255: G512-G521
22. Schmidt WE, Creutzfeldt W, Schleser A et al. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: Effects of loxiglumide. Am J Physiol 1991; 260: G107-G116
23. Niederau C, Faber S, Karaus M. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome. Gastroenterology 1992; 102: 1889-98
24. Meyer BM, Werth BA, Beglinger C et al. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989; 2: 12-5
25. Beglinger C, Hildebrand P, Adler G et al. Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man. Eur J Clin Invest 1992; 22: 827-34
26. Ritter RC, Brenner LA, Tamura CS. Endogenous CCK and the peripheral neural substrates of intestinal satiety. Ann N Y Acad Sci 1994; 713: 255-67
27. Crawley JN. Cholecystokinin-dopamine interactions. Trend Pharmacol Sci 1991; 12: 232-6
28. Baber NS, Dourish CT, Hill DR. The role of CCK caerulein, and CCK antagonists in nociception. Pain 1989; 39: 307-28
29. Kamilaris TC, Johnson EO, Calogero AE et al. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: Role of corticotropin-releasing hormone. Endocrinology 1992; 130: 1764-74
30. Logsdon CD. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am J Physiol 1986; 251: G487-G494
31. Klueppelberg UG, Molero X, Barrett RW, Miller LJ. Biochemical characterization of the cholecystokinin receptor on CHP212 human neuroblastoma cells. Mol Pharmacol 1990; 38: 159-63
32. Wank SA, Harkins R, Jensen RT et al. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc Natl Acad Sci USA 1992; 89: 3125-9
33. Wank SA, Pisegna JR, de Weerth A. Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc Natl Acad Sci USA 1992; 89: 8691-5
34. de Weerth A, Pisegna JR, Wank SA. The CCK-A receptor in gallbladder and pancreas are identical: Molecular cloning and expression. Am J Physiol 1992; 265 (6 Pt 1): G1116-G1121
35. de Weerth A, Pisegna JR, Huppi K, Wank SA. Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor. Biochem Biophys Res Commun 1993; 194: 811-8
36. de Weerth A, von Schrenck T, Gronewold M et al. Characterisation of CCK receptors in stomach smooth muscle: Evidence for two receptor subtypes. Biochim Biophys Acta 1997; 213-21
37. Ulrich CD, Ferber I, Holicky E et al. Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor. Biochem Biophys Res Commun 1993; 193: 204-11
38. Konturek JW, Stoll R, Gutwinska KM, Konturek SJ, Domschke W. Cholecystokinin in the regulation of gastric acid and endocrine pancreatic secretion in humans. Scand J Gastroenterol 1993; 28: 401-7
39. Grider JR, Makhlouf GM. Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder. Am J Physiol 1990; 259: G184-G190
40. Fourmy D, Zahidi A, Fahre R et al. Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas. Euro J Biochem 1987; 165: 683-92
41. Thornburn C, Friedman G, Dickinson C et al. Gastrin and colorectal cancer: A prospective study. Gastroenterology 1998; 115: 275-80
42. Sethi T, Herget T, Wu SV, Walsh JH, Rozengurt E. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Cancer Res 1993; 53: 5208-13
43. Savasta M, Palacios JM, Mengod G. Regional localization of the mRNA coding for the neuropeptide cholecystokinin in the rat brain studied by in situ hybridization. Neurosci Lett 1988; 93: 132-8
44. Harro J, Yasar E. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. Eur. J Pharmacol 1991; 193: 379-81
45. Kopin AS, Lee YM, McBride EW et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992; 89: 3605-9
46. Lee YM, Beinborn M, McBride EW et al. The human brain cholecystokinin-B/gastrin receptor. Cloning and characterization. J Biol Chem 1993; 268: 8164-9
47. Pisegna JR, de Weerth A, Huppi K, Wank SA. Molecular cloning of the human brain and gastric cholecystokinin receptor: Structure, functional expression and chromosomal localization. Biochem Biophys Res Commun 1992; 189: 296-303
48. de Weerth A. Pisegna JR, Wank SA. Molecular cloning of the guinea pig CCK-B receptor from gallbladder. Gastroenterology 1993; 104: A497 (Abstract)
49. Wank SA, Pisegna JR, de Weerth A. Cholecystokinin receptor family. Molecular cloning, structure. and functional expression in rat, guinea pig, and human. Ann N Y Acad Sci 1994; 66: 44-51
50. Kyte J, Doolittle RE. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982; 157: 105-32
51. Schulz I, Streb H, Bayerdoerffer E, Imamura K. Intracellular messengers in stimulus-secretion coupling of pancreatic acinar cells. J Cardiovasc Pharm 1986; 6: 11-23
52. Piiper A, Stryjek-Kaminska D, Klengel R, Zeuzem S. CCK, carharhol, and bombesin activate distinct PLC-heta isoenzymes via Gq/11 in rat pancreatic acinar membranes. Am J Physiol 1997; 272: R334-R340
53. Smrcka AV, Sternweis PC. Regulation of purified subtypes of phosphatidylinositol-specific phospholipase C beta by G protein alpha and beta gamma subunits. J Biol Chem 1993; 268: 9667-74
54. Pollo DA, Baldassare JJ, Honda T et al. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinasc C (PKC) in pancreatic acini. Biochim Biophys Acta 1994; 1224: 127-38
55. Lutz MP, Sutor SL, Abraham RT, Miller LJ. A role for cholecystokinin-stimulated protein tyrosine phosphorylation in regulated secretion by the pancreatic acinar cell. J Biol Chem 1993; 268: 11119-24
56. Susini C, Estival A, Scemama JL et al. Studies on human pancreatic acini: Action of secretagogues on amylase release and cellular cyclic AMP accumulation. Pancreas 1986; 1: 124-9
57. Talkad VD, Fortune KP, Polio DA et al. Direct demonstration of three different states of the pancreatic cholecystokinin receptor. Proc Natl Acad Sci USA 1994; 91: 1868-72
58. Huang SC, Fortune KP, Wank SA, Kopin AS, Gardner JD. Multiple affinity states of different cholecystokinin receptors. J Biol Chem 1994; 269: 26121-6
59. Roche S, Bali JP, Magous R. Involvement of a pertussis toxin-sensitive G protein in the action of gastrin on gastric parietal cells. Biochim Biophys Acta 1990; 1055: 287-94
60. Tsunoda Y, Yoshida H, Owyang C, Intracellular control of IP3-independent Ca2+ oscillations in pancreatic acini. Biochem Biophys Res Commun 1996; 222: 265-72
61. Jensen RT, Qian JM, Lin JT et al. Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors. Ann N Y Acad Sci 1994; 713: 88-106
62. Beglinger C, Solomon TE, Gyr K, Moroder L. Wuensch E. Exocrine pancreatic secretion in response to a new CCK-analog, CCK-33 and caerulein in dogs. Regul Pep 1984; 8: 291-6
63. Beglinger C, Fried M, Whitehouse I et al. Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. Digestion 1986; 35: 125-8
64. Dufresne M, Escrieut C, Clerc P et al. Molecular cloning, developmental expression and pharmacological characterization of the CCKB/gastrin receptor in the calf pancreas. Eur J Pharm 1996; 297: 165-79
65. Smith JP, Fantaskey AP, Liu G, Zagon IS. Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 1995; 268: R135-R141
66. de Weerth A, Jonas L, Schade R et al. Gastrin/cholecystokinin type B receptors in the kidney: Molecular, pharmacological and functional characterisation and localisation. Eur J Clin Invest 1998; 28: 7592-601
67. von Schrenck T, de Weerth A, Bechtel S et al. Evidence for CCK-B receptors in the guinea pig kidney: Localisation and characterization by 125-I-gastrin binding studies and RT-PCR. NaunynSchmiedeberg's Arch Pharmacol 1998; 358: 278-92
68. Blackmore M, Doherty E, Manning JE, Hirst BH. Autocrine growth stimulation of human renal Wilms' tumour G401 cells by a gastrin-like peptide. Int J Cancer 1994; 57: 385-91
69. Baldwin J. The probable arrangement of the helices in G Protein coupled receptors. EMBO J 1993; 12: 1693-703
70. Schertler G, Vill C, Henderson R. Projection structure of rhodopsin. Nature 1993; 362: 770-2
71. Beinborn M, Lee YM, McBride EW, Quinn SM, Kopin AS. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists. Nature 1993; 362: 348-50
72. Bläker M, Ren Y, Gordon M et al. Mutations within the CCK-B/gastrin receptor binding pocket interconvert the function of non-peptide agonists and antagonists. Mol Pharmacol 1998; 54: 857-63
73. Jagerschmidt A, Guillaume-Rousselet N, Vikland ML et al. His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity. Fur J Pharmacol 1996; 296: 97-106
74. Matamatiotis T, Baldwin G, His 381 of the rat CCK-B receptor is essential for the CCK-B versus the CCK-A receptor agonists selectivity. Biochem Biophys Res Commun 1994; 201: 1382-9
75. Kopin AS, McBride EW, Quinn SM, Kolakowski LF Jr., Beinborn M. The role of the cholecystokinin-B/gastrin receptor trunsmembrane domains in determining affinity for subtype-selective ligands. J Biol Chem 1995; 270: 5019-23
76. Caron M, Lefkowitz R. Catecholamine receptors: Structure, function, and regulation. Recent Prog Horm Res 1993; 48: 277-90
77. Schmitz F, Pratt DS, Wu MJ et al. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: Utilization of a novel Xenopus laevis cholecystokinin receptor. Mol Pharmacol 1996; 50: 436-41
78. Silvente-Poirol S, Wank SA. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin. J Biol Chem 1996; 271: 14698-706
79. Silvente-Poirot S, Escrient C, Wank SA. Role of the extracellular domains of the cholecystokinin receptors in agonist binding. Mol Pharmacol 1998; 54: 364-71
80. Ji Z, Hadac EM, Henne RM et al. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling. J Biol Chem 1997; 272: 24393-401
81. Kennedy K, Gigoux V, Escrieut C et al. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J Biol Chem 1997; 272: 29260-6
82. Hadac E, Pinon D, Ji Z et al. Direct identification of a second distinct site of contact between cholezystokinin and its receptor. J Biol Chem 1998; 273: 12988-93
83. Wang HL, Acsady L, Katona I et al. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors. J Neurochem 1997; 68: 1728-35
84. Jagerschmidt A, Guillaume N, Roques B, Noble F. Binding sites and transduction process of the cholecystokinin B receptor: Involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis. Mol Pharmacol 1998; 53: 878-85
85. Jagerschmidt A, Guillaume N, Goudreau N et al. Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increase antagonist binding and reduces signal transduction. Mol Pharmacol 1995; 48: 783-9
86. Beinborn M, Quinn S, Kopin A. Minor modifications of a CCK-B/gastrin receptor non-peptide antagonist confer a broad spectrum of functional properties. J Biol Chem 1998; 273: 14146-51
87. Beinborn M, Bläker M, Schaffer K, Kopin A. Two distinct mechanisms determine the ability of non-peptide ligands to activate the cholecystokinin-B/gastrin receptor. Gastroenterology 1998; A1127 (Abstract)
88. Schaffer K, McBride E, Beinborn M, Kopin A. Interspecies polymorphisms confer constitutive signaling activity to the mastomys CCK-B/gastrin receptor. Gastroenterology 1997; 112: A402 (Abstract)
89. Parma J, Duprez L, van Sande J et al. Somatic mutalions in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649-51
90. Kopin AS, McBride EW, Gordon MK et al. Interand intraspecies polymorphisms in the cholecystokinin B/gastrin receptor alter drug efficacy. Proc Natl Acad Sci 1997; 94: 11043-8
91. Bläker M, Ren Y, Sundarajan L, Beinborn M, Kopin A. Mutational analysis suggests different molecular mechanisms of CCK-B/receptor activation by endogenous peptides vs. synthetic drugs. Gastroenterology 1998; 114: A1133 (Abstract)
92. Wu V, Yang M, McRoberts JA et al. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells. J Biol Chem 1997; 272: 9037-42